TETROUS, INC., a leading regenerative medicine company today announced that it has completed the first surgical cases...
Inc.
Penumbra, Inc. (NYSE: PEN), the world’s largest thrombectomy company, announced the U.S. Food and Drug Administration (FDA)...
IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces...
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products
![Synaffix ABL Bio Partnership](https://wellnessnews24.com/wp-content/uploads/2023/09/pexels-cottonbro-studio-3952241-720x530.jpg)
2 min read
Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development...